knowledge -WSS

knowledge

author：focus 2025-10-01 10:39:18 - browse：28578

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medicare’s new pay boost for primary care is angering specialists

entertainment

WSS

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Senate committee scrutinizes Medicare Advantage brokers

FDA gives detailed accounting of AI

STAT Summit: How a Chicago ER doctor tackles gun violence

STAT Summit: Biotech founders on deal

STAT Summit: Michael J. Fox on progress in Parkinson's research

focus

knowledge

Wikipedia

Psychedelics group wrestles with new pharma identity

HHS leader on health, climate change and biopharma emissions

Medical leaders decry Supreme Court decision on affirmative action

STAT Readout Newsletter: Today's biggest biotech updates

Walensky prepares to leave CDC — and Congress — behind

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Dobbs anniversary: the lost opportunity of abortion as health care

Medical school prerequisites are outdated

Psychedelics group wrestles with new pharma identity

STAT Summit: Michael J. Fox on progress in Parkinson's research

focus

STAT Summit: How a Chicago ER doctor tackles gun violence

Healthy food access boosts outcomes in two studies

STAT Summit: Biotech founders on deal

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Experimental asthma app from Apple and Anthem shows promise

focus

focus

entertainment

Wikipedia